Capital Research & Management Co recently announced the acquisition of new stake in Keurig Dr Pepper Inc (NASDAQ:KDP). The institutional investor has increased its shareholding in the Consumer Defensive company by 16.96% to 94.29 million shares with purchase of 13.68 million shares. This fresh investment now brings its stake to 6.74% valued currently at $3.14 billion. In addition, The Vanguard Group, Inc. raised its holdings by 5.02 million to 78.18 million shares. And Capital Research & Management Co has lifted its position by 7.22% or 3.73 million shares – to 55.33 million shares.
Currently, there are 1.41B common shares owned by the public and among those 991.70M shares have been available to trade.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Insiders at the company have transacted a total of 87 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 57 of these insider trades were purchases, accounting for 2,370,839 shares. Insider sales of the common stock occurred on 30 occasions, with total insider shares sold totaling 88,025,308 shares.
The top 3 mutual fund holders in Keurig Dr Pepper Inc are Washington Mutual Investors Fund, Vanguard Total Stock Market ETF, and American Balanced Fund. Washington Mutual Investors Fund owns 43.84 million shares of the company’s stock, all valued at over $1.46 billion. The company bought an additional 2.04 million shares recently to bring their total holdings to about 3.14% of the shares outstanding. Vanguard Total Stock Market ETF bought 26074.0 shares to see its total holdings expand to 30.69 million shares valued at over $1.02 billion and representing 2.19% of the shares outstanding. American Balanced Fund bought 5.48 million shares to bring its total holdings to over 27.85 million shares at a value of $928.07 million. American Balanced Fund now owns shares totaling to 1.99% of the shares outstanding.
The company’s stock has a 5-day price change of 1.62% and 8.47% over the past three months. KDP shares are trading -3.93% year to date (YTD), with the 12-month market performance down to -8.36% lower. It has a 12-month low price of $27.66 and touched a high of $36.23 over the same period. KDP has an average intraday trading volume of 7.81 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -0.22%, -0.61%, and -0.58% respectively.
Institutional ownership of Keurig Dr Pepper Inc (NASDAQ: KDP) shares accounts for 63.53% of the company’s 1.41B shares outstanding. Mutual fund holders own 31.86%, while other institutional holders and individual stakeholders account for 44.76% and 18.93% respectively.
It has a market capitalization of $44.76B and a beta (3y monthly) value of 0.67. The stock’s trailing 12-month PE ratio is 23.33, while the earnings-per-share (ttm) stands at $1.37. The company has a PEG of 3.38 and a Quick Ratio of 0.22 with the debt-to-equity ratio at 0.57. Price movements for the stock have been influenced by the stock’s volatility, which stands at 1.32% over the week and 1.34% over the month.
Analysts forecast that Keurig Dr Pepper Inc (KDP) will achieve an EPS of $Kyndryl Holdings, Inc. for the current quarter, $21.14 for the next quarter and $Stocks for Type. The lowest estimate earnings-per-share for the quarter is $Kimbell Royalty Partners while analysts give the company a high EPS estimate of $Keurig Dr Pepper Inc.. Comparatively, EPS for the current quarter was $Fresh Del Monte Produce, Inc. a year ago. Earnings per share for the fiscal year are expected to increase by 5.94%, and 7.65% over the next financial year. EPS should grow at an annualized rate of 6.91% over the next five years, compared to -29.79% over the past 5-year period.
Looking at the support for the KDP, a number of firms have released research notes about the stock. Morgan Stanley stated their Equal-Weight rating for the stock in a research note on January 03, 2024, with the firm’s price target at $37.
